CINECA IRIS Institutional Research Information System

MARTINELLI, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.789
EU - Europa 5.943
AS - Asia 3.668
SA - Sud America 138
AF - Africa 130
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.403
CN - Cina 2.113
IT - Italia 2.096
SE - Svezia 1.135
DE - Germania 733
BG - Bulgaria 589
SG - Singapore 566
TR - Turchia 479
CA - Canada 381
UA - Ucraina 293
GB - Regno Unito 291
VN - Vietnam 274
FI - Finlandia 237
FR - Francia 137
BR - Brasile 127
RU - Federazione Russa 115
CH - Svizzera 111
IN - India 93
BE - Belgio 59
AT - Austria 58
HK - Hong Kong 57
CI - Costa d'Avorio 45
SN - Senegal 38
JP - Giappone 19
GR - Grecia 18
NG - Nigeria 16
IR - Iran 14
PL - Polonia 12
PK - Pakistan 11
KR - Corea 10
AU - Australia 9
ES - Italia 9
NL - Olanda 9
MA - Marocco 8
ID - Indonesia 7
RO - Romania 7
TN - Tunisia 7
BJ - Benin 5
IE - Irlanda 5
UZ - Uzbekistan 5
DK - Danimarca 4
PT - Portogallo 4
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
HU - Ungheria 3
IQ - Iraq 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
ZA - Sudafrica 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EE - Estonia 2
LI - Liechtenstein 2
LT - Lituania 2
MX - Messico 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 24.684
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.269
Ann Arbor 2.075
Houston 1.395
Fairfield 1.257
Chandler 1.008
Santa Clara 765
Ashburn 702
Serra 633
Milan 590
Sofia 588
Seattle 525
Chengdu 512
Shanghai 451
Wilmington 434
Beijing 418
Jacksonville 392
Izmir 379
Cambridge 372
Ottawa 356
New York 323
Singapore 317
Boardman 248
Princeton 240
Lawrence 217
Nanjing 202
Medford 180
Dong Ket 163
Des Moines 142
Dearborn 118
Marseille 106
Bern 103
Istanbul 87
Nanchang 86
Florence 79
Boulder 66
Jüchen 65
San Diego 65
Redwood City 59
Hong Kong 55
Los Angeles 55
London 49
Vienna 49
Brussels 46
Abidjan 45
Rome 45
Kunming 40
Dakar 38
Nürnberg 37
Shenyang 35
Kansas City 34
Ogden 33
Chicago 31
Jiaxing 31
Hebei 29
Tianjin 29
Changsha 28
Pune 28
Pisa 27
Detroit 26
Norwalk 26
Falls Church 25
Frankfurt am Main 25
Hangzhou 24
Bremen 23
Guangzhou 22
Fuzhou 21
Hefei 20
Washington 18
Auburn Hills 16
Indiana 16
Lagos 16
Orange 16
Grafing 15
San Francisco 15
Dallas 14
Lanzhou 14
Toronto 14
Düsseldorf 13
Rho 13
Phoenix 12
São Paulo 12
Warsaw 12
Quanzhou 11
Belo Horizonte 9
Louvain-la-Neuve 9
Frisco 8
Helsinki 8
Jinan 8
Lancaster 8
Leawood 8
Pieve Fosciana 8
Pistoia 8
Shenzhen 8
Alessandria 7
Rio de Janeiro 7
Tokyo 7
Wuhan 7
Costa Mesa 6
Council Bluffs 6
Genova 6
Totale 19.318
Salva come PNG Salva come JPEG
Nome #
null 595
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 249
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 241
Synthesis and 3D QSAR of New Pyrazolo[3,4-b]pyridines: Potent and Selective Inhibitors of A1 Adenosine Receptors 209
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. 192
Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligands 191
Synthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents 190
Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenase. 185
Identification of Lactate Dehydrogenase 5 Inhibitors using Pharmacophore- Driven Consensus Docking 176
Chimica - VI Edizione Copyright © 2017, EdiSES srl - Napoli 173
THERMODYNAMIC PROPERTIES OF ORGANIC COMPOUNDS IN AQUEOUS-SOLUTIONS - APPARENT MOLAL HEAT-CAPACITIES OF AMINES AND ETHERS 168
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 168
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 166
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 160
1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors 159
CONFORMATIONALLY RESTRAINED ANALOGS OF SYMPATHOMIMETIC CATECHOLAMINES - SYNTHESIS AND ADRENERGIC ACTIVITY OF TETRAHYDROBENZOCYCLOHEPTENE DERIVATIVES 158
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 158
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 156
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 155
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 154
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 153
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 152
Design, Synthesis and biological evaluation of new 1,8-naphthyridin-4(1h)-on-3-carboxamide and quinolin-4(1h)-on-3-carboxamide derivatives as CB2 selective agonists 151
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate-Benzenesulfonamide Conjugates 150
Conformationally restrained β -blocking oxime ethers: synthesis and β -adrenergic properties of diastereoisomeric anti and syn 2-(5-isoxazolidinyl)ethanolamines 150
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 149
D3 dopamine receptor subtype: which binding modes for such different ligands?, 147
Computational studies of EGFR inhibitors: Docking, 3D-QSAR analysis and virtual screening evaluation 146
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 146
CONFORMATIONAL STUDY OF ALPHA-BLOCKING ADRENERGIC-DRUGS WITH BENZODIOXANE STRUCTURE 145
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 145
Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor 144
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 142
N-ALKYL-NOR-TROPINE ESTERS OF 2-PHENYL-CYCLOHEXENIC ACIDS AS NEW BRONCHODILATOR AGENTS - EFFECT OF STRUCTURAL AND CONFORMATIONAL MODIFICATIONS ON AFFINITY FOR MUSCARINIC RECEPTORS 141
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes 141
An overview of recent developments in GPCR modelling: methods and validation 141
Role of the acyloxymethyl moiety in eliciting the adrenergic ß-blocking activity of 3-acyloxypropanolamines 139
COMPOUNDS INHIBITING THE ENZYME LACTATE DEHYDROGENASE (LDH), PHARMACEUTICAL COMPOSITIONS AND USES THEREOF 139
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 139
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 138
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides 138
MOLECULAR-ORBITAL STUDIES ON MECHANISM OF DRUG-RECEPTOR INTERACTION .2. BETA-ADRENERGIC DRUGS - APPROACH TO EXPLAIN ROLE OF AROMATIC MOIETY 137
Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5 137
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 135
Cannabinoid CB2/CB1 Selectivity. Receptor Modeling and Automated Docking Analysis 135
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 135
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 134
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 134
Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds 134
Identification of new FYN kinase inhibitors using a FLAP-based approach 134
A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by using a Pharmacophore-Based Approach 134
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 133
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 132
Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies 132
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 130
Conformationally Restrained Analogs of Sympathomimetic Catecholamines. Synthesis, Conformational Analysis, and Adrenergic Activity of Isochroman Derivatives 130
Conformationally restrained analogues of sympathomimetic catecholamines: Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2′,5′- morpholines] 129
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 129
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 126
Olivetol- and Resorcinol-Anandamide “hybrids”: design, synthesis, binding and molecular modeling of potent cannabinoid receptor ligands 126
D3 dopamine receptor subtype: which binding modes for such different ligands? 126
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 126
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 126
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 126
Conformational effects on the activity of drugs. 13. A revision of previously proposed models for the activation of alfa- and beta-adrenergic receptors 125
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 125
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists 125
Computational Studies on Translocator Protein (TSPO) and its Ligands 124
Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor 124
An interdisciplinary approach to the design of new structures active at the beta-adrenergic receptor. Aliphatic oxime ether derivatives 124
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation 124
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 124
Structure-Activity Relationship Studies of a New Series of Imidazo2,1-fpurinones as Potent and Selective A3 Adenosine Receptor Antagonists 124
Design of transthyretin amyloidosis inhibitors: A docking and virtual screening approach 123
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 123
A CONFORMATIONAL APPROACH TO HISTAMINE H-2-RECEPTOR ANTAGONISTS 122
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach 122
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 122
Synthesis and antimicrobial properties of substituted 3-aminoxy-(E)-2-methoxyiminopropionyl penicillins and cephalosporins 121
Novel aminopteroil-sulfonamide derivatives as inhibitors of dihydrofolate reductase and carbonic anhydrase, with potential anti tumor activity 121
MOLECULAR DESIGN, SYNTHESIS, AND ANTIINFLAMMATORY ACTIVITY OF A SERIES OF BETA-AMINOXYPROPIONIC ACIDS 118
Triazole-substituted N-hydroxyindol-2-carboxylates as inhibitors of isoform 5 of human lactate dehydrogenase (hLDH5) 118
Different Binding Modes of Structurally Diverse Ligands for Human D3DAR 118
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 118
Design, synthesis, and biological evaluation of 1,8-naphthyridin-2(1H)-on-3-carboxamide, quinolin-2(1H)-on-3-carboxamide and 2-oxo-1,2-dihydropyridine-3-carboxamide derivatives as CB2 selective ligands 117
null 117
Substituted Pyrazolo3,4-bpyridines as Potent A1 Adenosine Antagonists: Synthesis, Biological Evaluation, and Development of an A1 Bovine Receptor Model 117
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 117
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo 117
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 116
The cannabinoid CB2/CB1 selectivity. Homology modelling and automated docking analysis 115
Indoles and Related Compounds as Cannabinoid Ligands, 115
3D-QSAR and virtual screening studies for the translocator protein(TSPO) 115
Structural optimization of 4-chlorobenzoylpiperidine derivatives for the development of potent, reversible and selective monoacylglycerol lipase (MAGL) inhibitors 115
Synthesis and biological evaluation of 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists 114
QSAR of Carbonic Anhydrase Inhibitors and Their Impact on Drug Design 114
Computational Studies of Epidermal Growth Factor Receptor for Docking Reliability, Three-Dimensional Quantitative Structure-Activity Relationship Analysis, and Virtual Screening Studies 114
Transthyretin amyloidosis: a computational approach toward the design of new inhibitors 113
Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole 113
ROLE OF THE (ACYLOXY)METHYL MOIETY IN ELICITING THE ADRENERGIC BETA-BLOCKING ACTIVITY OF 3-(ACYLOXY)PROPANOLAMINES 113
Totale 14.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.618
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.595 0 0 0 0 0 0 422 247 317 246 274 89
2020/20211.875 174 188 115 72 205 82 100 197 154 138 112 338
2021/20222.630 59 197 74 185 450 344 78 145 84 75 167 772
2022/20232.902 374 368 191 275 312 430 28 197 494 21 167 45
2023/20242.193 358 262 267 152 333 386 87 43 41 32 39 193
2024/20252.358 38 252 113 385 687 597 286 0 0 0 0 0
Totale 24.965